Inventor

Julian Alexander Barden

Inventor

North Ryde, AU

Overview

2007–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 29 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%

C07KPeptides26%

A61KPreparations for medical, dental or toiletry purposes24%

G01NInvestigating or analysing materials by determining their chemical or physical properties19%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

PatentTitleYear

10,988,532Anti P2X2021 10,597,451Methods of treating cancer with a P2X7 peptide2020 10,543,262Combination therapy utilizing P2X7 peptides2020 10,450,380Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor2019 10,245,308Combination therapy utilizing P2X7 peptides2019 10,238,716Anti-P2X2019 10,232,025Method for minimising progression of cancer in companion animals2019 10,053,508Anti P2X7 receptor antibodies and fragments thereof2018 9,944,701Methods of treating cancer with antibodies that bind P2X7 receptors2018 9,688,771'Anti P2X7 receptor antibodies and fragments thereof'2017 9,663,584'Antibodies to non-functional P2X7 receptor'2017 9,566,318'Combination therapy'2017 9,562,094'Companion animal treatments'2017 9,428,587'Antibodies to non-functional oligomeric P2X7 receptors and methods of use thereof'2016 9,328,155'Peptides for inducing antibodies to a non-functional P2X7 receptor'2016 9,181,320'Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor'2015 9,127,059'Anti P2X7 receptor antibodies and fragments thereof'2015 8,835,609'Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof'2014 8,658,385'Purinergic (P2X) receptors in extra-cellular body fluid'2014 8,597,643'Antibodies for binding to non-functional P2X7 receptors in trimeric form'2013 8,440,186'P2X7 epitopes'2013 8,399,617'Non-functional P2X7 receptor'2013 8,293,491'Purinergic (P2X) receptors in extra-cellular body fluid'2012 8,080,635'Non-functional P2X7 receptor'2011 8,067,550'Hybridomas producing antibodies against non functional P2X7 receptor'2011 7,888,473'Non-functional P2X7 receptor'2011 7,531,171'Antibodies to non-functional P2X7 receptor'2009 7,326,415'Antibodies to non-functional P2X7 receptor'2008 7,183,064'Method for identifying pre-neoplastic and/or neoplastic states in mammals'2007

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2007–2013Based in Marsfield, AU· patent location history

2011–2017Patents assigned to BIOSCEPTRE INT LTD (14)· patent assignee history

2011–2017Patents assigned to BARDEN JULIAN ALEXANDER (11)· patent assignee history

2011–2017Patents assigned to GIDLEY-BAIRD ANGUS (10)· patent assignee history

2011Based in New South Wales, AU· patent location history

2012–2021Based in North Ryde, AU· patent location history

2016–2021Patents assigned to BIOSCEPTRE AUST PTY LTD (10)· patent assignee history

2017Patents assigned to BIOSCEPTRE (AUST) PTY LTD (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BIOSCEPTRE INT LTD	14	2011–2017
BARDEN JULIAN ALEXANDERself	11	2011–2017
BIOSCEPTRE AUST PTY LTD	10	2016–2021
GIDLEY-BAIRD ANGUS	10	2011–2017
BIOSCEPTRE (AUST) PTY LTD	4	2017

Locations

Location	Patents	Span
North Ryde, AU	22	2012–2021
Marsfield, AU	6	2007–2013
New South Wales, AU	1	2011